MIMETAS

MIMETAS

MIMETAS

MIMETAS develops predictive Organ-on-a-Chip cell culture models for better, more reliable and tailored medicines.
Founded
2013
Raised
$22.1M
Follow us
Featured on
Alexa global traffic share
Twitter followers
Latest funding
$20,500,000
Venture capital (Series B) - 2018
Korys InnovationQuarter Cathay Venture +3
$1,600,000
Venture capital (Series B) - 2016
Team Size
10+
Employees
$20,500,000 Venture capital (Series B)
FinSMEs

Mimetas Secures $20M in Series B Financing

Apps & Services Science
$1,600,000 Venture capital (Series B)
manufacturingchemist

Mimetas receives US$1.6m in funding to develop organ-on-a-chip neurotoxicity models

Science Health